Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya
Status:
Recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
Women with mild/moderate anemia who are seeking contraception will be randomized to a
levonorgestrel (LNG) intrauterine system (IUS) or an LNG/ethinyl estradiol (EE)/ferrous
fumarate combined oral contraceptive (COC) regimen and followed prospectively for 18 months.
Approximately 600 participants will be enrolled. The primary hypothesis is that the mean
change in hemoglobin concentration will be significantly higher in the group assigned to the
LNG IUS compared to the group assigned to COCs
Phase:
N/A
Details
Lead Sponsor:
FHI 360
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)